LeMaitre Vascular Inc (LMAT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:LeMaitre Vascular Inc (LMAT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7260
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LeMaitre Vascular Inc (LeMaitre Vascular) provides medical devices and services for the treatment of peripheral vascular diseases. The company develops, manufactures, and markets disposable and implantable devices that vascular surgeons use in arteries and veins outside the heart in open vascular surgeries and minimally invasive procedures. Its product portfolio includes angioscopes, balloon catheters, carotid shunts, radiopaque tapes, powered phlebectomy devices, valvulotomes, remote endarterectomy devices, vascular grafts, patches and closure systems. It also offers human tissue cryopreservation services. LeMaitre Vascular sells its products through direct sales force and subsidiaries in North America, Europe, Asia-Pacific , and through distributors in other geographies. LeMaitre Vascular is headquartered in Burlington, Massachusetts, the US.

LeMaitre Vascular Inc (LMAT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LeMaitre Vascular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
LeMaitre Vascular Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
LeMaitre Vascular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
LeMaitre Vascular Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
LeMaitre Vascular Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
LeMaitre Vascular Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
LeMaitre Vascular Acquires Clot Management Business from Applied Medical Resources for USD14.2 Million 10
LeMaitre Vascular Acquires Assets of Restore Flow Allografts 11
CryoLife Sells Distribution Rights of ProCol Vascular Bioprosthesis to LeMaitre Vascular for USD2 Million 12
LeMaitre Vascular Acquires ProCol Vascular Bioprosthesis Product Line from Hancock Jaffe Labs for USD0.6 Million 13
LeMaitre Vascular Acquires Angioscope Product Line from Applied Medical for USD0.4 Million 14
LeMaitre Vascular Acquires Assets Of InaVein 15
LeMaitre Vascular Finalizes Acquisition of XenoSure From Neovasc For US$5 Million 16
Venture Financing 18
Restore Flow Allografts Raises US$0.7 Million In Venture Financing 18
Equity Offering 19
LeMaitre Vascular Raises USD11.5 Million in Public Offering of Shares 19
Asset Transactions 21
Symmetry Surgical Acquires General Surgery Product Lines from LeMaitre Vascular for USD7.4 Million 21
LeMaitre Vascular Acquires Assets of Restore Flow Allografts 22
Acquisition 23
LeMaitre Vascular Acquires Xenotis for USD7.7 Million 23
LeMaitre Vascular Acquires Clinical Instruments International For US$1 Million 24
LeMaitre Vascular Inc – Key Competitors 25
LeMaitre Vascular Inc – Key Employees 26
LeMaitre Vascular Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 29
Financial Announcements 29
Oct 04, 2018: LeMaitre Vascular Announces Preliminary Q3 2018 Results 29
Apr 25, 2018: LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%) 30
Feb 21, 2018: LeMaitre Reports Net Income Of $4.3mm In Q4 2017 31
Oct 26, 2017: LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%) 32
Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) 33
Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) 34
Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
LeMaitre Vascular Inc, Medical Equipment, Key Facts, 2017 2
LeMaitre Vascular Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
LeMaitre Vascular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
LeMaitre Vascular Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
LeMaitre Vascular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
LeMaitre Vascular Inc, Deals By Market, 2012 to YTD 2018 8
LeMaitre Vascular Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
LeMaitre Vascular Acquires Clot Management Business from Applied Medical Resources for USD14.2 Million 10
LeMaitre Vascular Acquires Assets of Restore Flow Allografts 11
CryoLife Sells Distribution Rights of ProCol Vascular Bioprosthesis to LeMaitre Vascular for USD2 Million 12
LeMaitre Vascular Acquires ProCol Vascular Bioprosthesis Product Line from Hancock Jaffe Labs for USD0.6 Million 13
LeMaitre Vascular Acquires Angioscope Product Line from Applied Medical for USD0.4 Million 14
LeMaitre Vascular Acquires Assets Of InaVein 15
LeMaitre Vascular Finalizes Acquisition of XenoSure From Neovasc For US$5 Million 16
Restore Flow Allografts Raises US$0.7 Million In Venture Financing 18
LeMaitre Vascular Raises USD11.5 Million in Public Offering of Shares 19
Symmetry Surgical Acquires General Surgery Product Lines from LeMaitre Vascular for USD7.4 Million 21
LeMaitre Vascular Acquires Assets of Restore Flow Allografts 22
LeMaitre Vascular Acquires Xenotis for USD7.7 Million 23
LeMaitre Vascular Acquires Clinical Instruments International For US$1 Million 24
LeMaitre Vascular Inc, Key Competitors 25
LeMaitre Vascular Inc, Key Employees 26
LeMaitre Vascular Inc, Other Locations 27
LeMaitre Vascular Inc, Subsidiaries 27

List of Figures
LeMaitre Vascular Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
LeMaitre Vascular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
LeMaitre Vascular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
LeMaitre Vascular Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
LeMaitre Vascular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
LeMaitre Vascular Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
LeMaitre Vascular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
LeMaitre Vascular Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[LeMaitre Vascular Inc (LMAT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Escalon Medical Corp (ESMC):医療機器:M&Aディール及び事業提携情報
    Summary Escalon Medical Corp (Escalon) is a medical device company with primary focus on ophthalmology. It carries out the development and sale of ophthalmic medical devices. Its major products include A-Scan and B-Scan diagnostic tools, UBM high frequency/high resolution ultrasound devices, pachyme …
  • Partner Reinsurance Asia Pte. Ltd.:企業の戦略・SWOT・財務分析
    Partner Reinsurance Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Partner Reinsurance Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Jardine Cycle & Carriage Limited:企業の戦略・SWOT・財務分析
    Jardine Cycle & Carriage Limited - Strategy, SWOT and Corporate Finance Report Summary Jardine Cycle & Carriage Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • The Chugoku Electric Power Co Inc:発電所・企業SWOT分析
    The Chugoku Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Continental Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Continental Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Continental Resources Inc (Continental Resources) is an oil and gas company involved in the distribution of fuel and related products and services. The company offerings include supply fulf …
  • SYNNEX Corporation:企業の戦略・SWOT・財務情報
    SYNNEX Corporation - Strategy, SWOT and Corporate Finance Report Summary SYNNEX Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The New York Times Company (NYT):企業の財務・戦略的SWOT分析
    The New York Times Company (NYT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Kazia Therapeutics Ltd (KZA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kazia Therapeutics Limited (Kazia Therapeutics), is a clinical stage biotechnology company which focuses on the discovery and development of anti-cancer drugs. It develops its products based on three drug technology platforms, phosphoinositide 3-kinase (PI3K) inhibitors, anti-tropomyosins (A …
  • Werner Enterprises, Inc.:企業の戦略・SWOT・財務情報
    Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Alltech Inc:企業の戦略的SWOT分析
    Alltech Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Barrett Business Services Inc (BBSI):企業の財務・戦略的SWOT分析
    Summary Barrett Business Services Inc (BBSI) is a management consulting company that offers business management solutions. The company’s services include human capital management, preferred payroll, and staffing. Its payroll services handles deductions, liens, tax levies, tax payments, w-2s, and wag …
  • Cipher Pharmaceuticals Inc (CPH):企業の財務・戦略的SWOT分析
    Summary Cipher Pharmaceuticals Inc (Cipher) is a pharmaceutical company that develops skin care solutions. The company provides products such as actikerall, a topical solution indicated for the treatment of hyperkeratotic actinic keratosis; beteflam, a topical patch used for the treatment of mild to …
  • Orell Fussli Holding AG:戦略・SWOT・企業財務分析
    Orell Fussli Holding AG - Strategy, SWOT and Corporate Finance Report Summary Orell Fussli Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • DPR Construction, Inc.:企業の戦略・SWOT・財務情報
    DPR Construction, Inc. - Strategy, SWOT and Corporate Finance Report Summary DPR Construction, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • RattanIndia Power Ltd (RTNPOWER):企業の財務・戦略的SWOT分析
    RattanIndia Power Ltd (RTNPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • GP JOULE GmbH:電力:M&Aディール及び事業提携情報
    Summary GP JOULE GmbH (GP JOULE) is an alternative energy company that offers natural resource conservation solutions. The company offers products such as solar carports and movers, and green house systems. Its services include planning, engineering, procurement, and construction, operations, and ma …
  • Yanmar Co Ltd:企業の戦略的SWOT分析
    Yanmar Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Xellia Pharmaceuticals ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary Xellia Pharmaceuticals ApS (Xellia), a subsidiary of Novo A/S is a healthcare products provider that offers fermented and semi-synthetic APIs and injectable finished dosage forms. The company offers strain and fermentation development with bacteria and fungi. It provides injectable products …
  • ITV plc (ITV):企業の財務・戦略的SWOT分析
    ITV plc (ITV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Xcel Energy Inc:発電所・企業SWOT分析
    Xcel Energy Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆